JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) announced today that it will present updated preclinical data from its proprietary J-Brain Cargo ® -applied adeno-associated virus (AAV) vector gene ...

VectorY Therapeutics, a biotech company developing disease-modifying vectorized antibody therapies for the treatment of ...